Ira Bio Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2024)
- Profit 76.89%
(FY 2024)
- Ebitda 76.89%
(FY 2024)
- Net Worth -4.18%
(FY 2024)
- Total Assets -15.90%
(FY 2024)
About Ira Bio
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Murali Penumetsa and Sivarama Kalidindi serve as directors at the Company.
- CIN/LLPIN
U24110TG2022PTC163345
- Company No.
163345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ira Bio?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Penumetsa  | Director | 01-Jun-2022 | Current |
| Sivarama Kalidindi | Director | 01-Jun-2022 | Current |
Financial Performance of Ira Bio.
Ira Bio Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 76.89% increase in profit. The company's net worth dipped by a decrease of 4.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ira Bio?
Unlock access to Ira Bio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Swathi Landmark Properties Private LimitedActive 19 years 9 months
Murali Penumetsa is a mutual person
- Yashoda Infrastructure Projects Private LimitedActive 25 years 3 months
Murali Penumetsa is a mutual person
- Keerthi Landmark Properties Private LimitedActive 19 years 9 months
Murali Penumetsa is a mutual person
- Medisysinfo Medical Information Technology Private LimitedActive 13 years 6 months
Murali Penumetsa and Sivarama Kalidindi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ira Bio?
Ira Bio has a workforce of 0 employees as of Jan 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ira Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ira Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
